ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0995

Resident Memory T Cells Stimulate Pathogenic Activity in Fibroblast-like Synoviocytes

Madison Mangin1, Yang Yang2, Yusuke Miyashita2 and Margaret Chang2, 1Boston Children's Hospital, St Simons Island, GA, 2Boston Children's Hospital, Boston, MA

Meeting: ACR Convergence 2025

Keywords: Fibroblasts, Synovial, Inflammation, rheumatoid arthritis, T Cell

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 27, 2025

Title: (0978–1006) T Cell Biology & Targets in Autoimmune & Inflammatory Disease Poster

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Rheumatoid arthritis (RA) is an autoimmune disease characterized by joint specific memory. We previously demonstrated that joint-specific memory is mediated by CD8+ synovial resident memory T (TRM) cells that persist in arthritic joints during remission and can mediate arthritis flares. Further, we found that fibroblast-like synoviocytes (FLS) facilitate the formation of TRM through IL-15 production. As cell-cell interactions can be bidirectional, we investigated the effects of TRM on FLS pathogenicity.

Methods: TRM were generated through two-week co-culture with FLS isolated from RA synovium in the presence of IL-15. TRM development was validated by cell surface markers, gene expression profile and enhanced Bodipy free fatty acid uptake. TRM were purified through multi-step magnetic nanobead sorting for CD62L-, CD25- and CD69+ cells. Purified TRM cells were stimulated with anti-CD3/CD28 dynabeads for 24 hours then co-cultured with new unstimulated FLS. After 48 to 72 hours, FLS were collected and assayed for phenotypic markers of cellular activation by flow cytometry, for pathogenic gene expression by qPCR, and for protein expression by ELISA.

Results: TRM generated through FLS co-culture displayed surface phenotype CD45RO+CD62L-CCR7-HLA-DR-CD25-CD69+ with variable CD103 and CD49a expression. These cells also displayed enhanced free fatty uptake and a gene expression signature consistent with TRM. FLS co-cultured with purified TRM upregulated surface expression of HLA-DR and ICAM-1 similar to FLS stimulated with TNF alone. TRM-stimulated FLS also increased expression of inflammatory cytokines (IL-6, IL-8), chemokines (CCL5) and matrix metalloproteinases (MMP1, MMP3).

Conclusion: We previously showed that FLS facilitate synovial TRM development. We now demonstrate that TRM also promote FLS activation, stimulating the expression of inflammatory cytokines, chemokines and matrix metalloproteinases by FLS, thus contributing to arthritis pathogenesis.


Disclosures: M. Mangin: None; Y. Yang: None; Y. Miyashita: None; M. Chang: None.

To cite this abstract in AMA style:

Mangin M, Yang Y, Miyashita Y, Chang M. Resident Memory T Cells Stimulate Pathogenic Activity in Fibroblast-like Synoviocytes [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/resident-memory-t-cells-stimulate-pathogenic-activity-in-fibroblast-like-synoviocytes/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/resident-memory-t-cells-stimulate-pathogenic-activity-in-fibroblast-like-synoviocytes/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology